Another 'non-share price moving' announcement trying to distract everyone from the fact that the RX5 trial will never be completed. And why do we care whether the APs are male or female?? Pathetic
Ann: Emyria Expands Specialist AP Team - First Female for MDMA-AT, page-2
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EMD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.4¢ |
Change
-0.001(2.86%) |
Mkt cap ! $13.90M | |||
| Open | High | Low | Value | Volume |
| 3.4¢ | 3.5¢ | 3.4¢ | $4.525K | 132.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 436779 | 3.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.5¢ | 100000 | 1 |
View Market Depth
| Last trade - 15.56pm 16/08/2024 (20 minute delay) ? |
| EMD (ASX) Chart |